title: Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders.
abstract: Obesity and metabolic syndrome in association with an increased risk of cardiovascular disease and type II diabetes are significant problems that contribute to lower life expectancy of patients with schizophrenia. Understanding the pharmacological mechanisms of the current antipsychotic treatment is clearly the key to the improvement of pharmacotherapy, to avoid or to mitigate the metabolic adverse effects.
authors.affiliation: Ph.D. Student in Pharmacology, University of Medicine and Pharmacy of Craiova.
authors.forename: Ileana Cristina
authors.initials: IC
authors.lastname: Miron
authors.affiliation: Ph.D. Student in Pharmacology, University of Medicine and Pharmacy of Craiova.
authors.forename: Victoriţa Cătălina
authors.initials: VC
authors.lastname: Baroană
authors.affiliation: Pharmacology Discipline, Faculty of Medicine, University of Medicine and Pharmacy of Craiova.
authors.forename: Florica
authors.initials: F
authors.lastname: Popescu
authors.affiliation: Pharmacology Discipline, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova.
authors.forename: Floriana
authors.initials: F
authors.lastname: Ionică
keywords: antipsychotic; metabolic disorders; pharmacological mechanisms